Pneumococcal infections and homelessness

J Prev Med Hyg. 2022 Jan 31;62(4):E950-E957. doi: 10.15167/2421-4248/jpmh2021.62.4.1805. eCollection 2021 Dec.

Abstract

Objective: To assess the prevalence of pneumococcal nasopharyngeal carriage, the role of potential risk factors, and the pneumococcal vaccination coverage among sheltered homeless people in Marseille, France.

Methods: During the winters 2015-2018, we enrolled 571 sheltered homeless males and 54 non-homeless controls. Streptococcus pneumoniae was directly searched from nasal/pharyngeal samples using real-time polymerase chain reaction.

Results: The homeless people were mostly migrants from African countries, with a mean age of 43 years. Pneumococcal vaccination coverage was low (3.1%). The overall pneumococcal carriage rate was 13.0% and was significantly higher in homeless people (15.3% in 2018) than in controls (3.7%), with p = 0.033. Among homeless people, being aged ≥ 65 years (1.97, 95% CI; 1.01-3.87), living in a specific shelter (OR = 1.80, 95% CI: 1.06-3.05), and having respiratory signs and symptoms at the time of enrolment (OR = 2.55, 95% CI: 1.54-4.21) were independently associated with pneumococcal carriage.

Conclusion: Pneumococcal nasopharyngeal carriage, which is a precursor for pneumococcal disease in at-risk individuals, is frequent among French homeless people. Studies conducted in other countries have also reported outbreaks of pneumococcal infections in homeless people. Pneumococcal vaccination should be systematically considered for sheltered homeless people in France, as is being done in Canada since 2008.

Keywords: Homelessness; Invasive pneumococcal diseases; Pneumococcal vaccination; Real-time polymerase chain reaction; Streptococcus pneumoniae.

MeSH terms

  • Adult
  • Carrier State / epidemiology
  • Humans
  • Ill-Housed Persons*
  • Infant
  • Male
  • Nasopharynx
  • Pneumococcal Infections* / epidemiology
  • Pneumococcal Infections* / prevention & control
  • Pneumococcal Vaccines
  • Prevalence
  • Streptococcus pneumoniae

Substances

  • Pneumococcal Vaccines